{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:22:48Z","timestamp":1789636968859,"version":"4.0.0"},"reference-count":50,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15fk0108039h0001\/0002\/0003"],"award-info":[{"award-number":["15fk0108039h0001\/0002\/0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2016,10,27]]},"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:p>With the incidence and mortality rates of Ebola virus disease (EVD) in Guinea, Liberia and Sierra Leone now at zero and reports of the largest and most complex EVD outbreak in history no longer on the front pages of newspapers worldwide, the urgency of that crisis seems to have subsided. During this lull after the storm and before the next one, the international community needs to engage in a \u2018lessons-learned\u2019 exercise with respect to our collective scientific, clinical and public health preparedness. This engagement must identify pragmatic, innovative mechanisms at multinational, national and community levels that allow research and development of next generation diagnostics and therapeutics, the safe and effective practice of medicine, and the maintenance of public health to keep pace with the rapid epidemiological dynamics of EVD and other deadly infectious diseases.<\/jats:p>","DOI":"10.1136\/bmjgh-2016-000180","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T21:40:31Z","timestamp":1480023631000},"page":"e000180","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Responding to ever-changing epidemiological dynamics of Ebola virus disease"],"prefix":"10.1136","volume":"1","author":[{"given":"Yuki","family":"Maehira","sequence":"first","affiliation":[{"name":"St. Luke's International University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kurosaki","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Saito","sequence":"additional","affiliation":[{"name":"National Institute of Public Health, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Tarui","sequence":"additional","affiliation":[{"name":"Keio University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis J M","family":"Malvy","sequence":"additional","affiliation":[{"name":"Inserm 1219, University of Bordeaux & Division of Clinical Tropical Medicine, CHU de Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"St. Luke's International University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"2025073013074257000_1.3.e000180.1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71075-8"},{"key":"2025073013074257000_1.3.e000180.2","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(14)62043-2","article-title":"First trials for Ebola treatments announced","volume":"384","author":"Mohammadi","year":"2014","journal-title":"Lancet"},{"key":"2025073013074257000_1.3.e000180.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2015.12.005"},{"key":"2025073013074257000_1.3.e000180.4","unstructured":"Sissoko D , Folkesson E , Abdoul M , et al . Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Abstract No. 103-ALB. Washington, USA: Presented at the CROI, 2015."},{"key":"2025073013074257000_1.3.e000180.5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001967"},{"key":"2025073013074257000_1.3.e000180.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)71047-3"},{"key":"2025073013074257000_1.3.e000180.7","unstructured":"World Health Organization. Ebola Response Phase 3. Framework for achieving and sustaining a resilient zero. Geneva, Switzerland: WHO, September 2015."},{"key":"2025073013074257000_1.3.e000180.8","doi-asserted-by":"publisher","DOI":"10.3201\/eid2202.151278"},{"key":"2025073013074257000_1.3.e000180.9","first-page":"e008859","article-title":"Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations","volume":"6","author":"Thorson","year":"2016","journal-title":"BMJ"},{"key":"2025073013074257000_1.3.e000180.10","doi-asserted-by":"crossref","unstructured":"Deen GF , Knust B , Broutet N , et al . Ebola RNA persistence in semen of Ebola virus disease survivors-preliminary report. N Eng J Med 2015. doi:10.1056\/NEJMoa1511410 doi:10.1056\/NEJMoa1511410","DOI":"10.1056\/NEJMoa1511410"},{"key":"2025073013074257000_1.3.e000180.11","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.12.e63"},{"key":"2025073013074257000_1.3.e000180.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.015"},{"key":"2025073013074257000_1.3.e000180.13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.977-981.2002"},{"key":"2025073013074257000_1.3.e000180.14","unstructured":"World Health Organization. Annex 3: Considerations for the selection of rapid antigen detection tests for the diagnosis of Ebola virus disease. Emergency Guidance. Selection and Use of Ebola in vitro diagnostic (IVD) assays. Geneva, Switzerland: WHO, June 2015."},{"key":"2025073013074257000_1.3.e000180.15","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2015.20.12.21073"},{"key":"2025073013074257000_1.3.e000180.16","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9071(200004)60:4<463::AID-JMV15>3.0.CO;2-M"},{"key":"2025073013074257000_1.3.e000180.17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61042-X"},{"key":"2025073013074257000_1.3.e000180.18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw261"},{"key":"2025073013074257000_1.3.e000180.19","unstructured":"ReEBOV Antigen Rapid Test (Ebolavirus VP40 Antigen Detection), Instruction for Use. For Use under Emergency Use Authorization (EUA) Only (in vitro diagnostic use), Corgenix, Inc. Colorado, USA. 2015."},{"key":"2025073013074257000_1.3.e000180.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw246"},{"key":"2025073013074257000_1.3.e000180.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2016.01.017"},{"key":"2025073013074257000_1.3.e000180.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2015.04.001"},{"key":"2025073013074257000_1.3.e000180.23","doi-asserted-by":"publisher","DOI":"10.1086\/520600"},{"key":"2025073013074257000_1.3.e000180.24","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02724-15"},{"key":"2025073013074257000_1.3.e000180.25","doi-asserted-by":"crossref","first-page":"e0145896","DOI":"10.1371\/journal.pone.0145896","article-title":"Analytical performance characteristics of the Cepheid GeneXpert Ebola assay for the detection of Ebola virus","volume":"10","author":"Pinsky","year":"2015","journal-title":"PLoS ONE"},{"key":"2025073013074257000_1.3.e000180.26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0004472"},{"key":"2025073013074257000_1.3.e000180.27","doi-asserted-by":"publisher","DOI":"10.1038\/nature16041"},{"key":"2025073013074257000_1.3.e000180.28","doi-asserted-by":"crossref","first-page":"20(44)","DOI":"10.2807\/1560-7917.ES.2015.20.44.30053","article-title":"Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015","volume":"20","author":"Faye","year":"2015","journal-title":"Euro Surveill"},{"key":"2025073013074257000_1.3.e000180.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)61117-5"},{"key":"2025073013074257000_1.3.e000180.30","doi-asserted-by":"publisher","DOI":"10.1177\/2051013615611017"},{"key":"2025073013074257000_1.3.e000180.31","unstructured":"High Council for Public Health. Opinion. Relating to the management of healthcare worker (HCW) in care settings who are victims of an AEB\/AEV from a patient who is a confirmed index case of Ebola virus disease. Haut Conseil de la Sant\u00e9 Publique, France. 4 December 2014. http:\/\/www.hcsp.fr\/Explore.cgi\/avisrapportsdomaine?clefr=471 (accessed 5 Sep 2016)."},{"key":"2025073013074257000_1.3.e000180.32","doi-asserted-by":"crossref","first-page":"150019","DOI":"10.1038\/sdata.2015.19","article-title":"A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making","volume":"2","author":"Van Kerkhove","year":"2015","journal-title":"Sci Data"},{"key":"2025073013074257000_1.3.e000180.33","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00228-5"},{"key":"2025073013074257000_1.3.e000180.34","first-page":"e130","article-title":"Ebola crisis: the unequal impact on women and children's health","volume":"3","author":"Men\u00e9ndez","year":"2015","journal-title":"Lancet"},{"key":"2025073013074257000_1.3.e000180.35","doi-asserted-by":"crossref","first-page":"pii: 20983","DOI":"10.2807\/1560-7917.ES2014.19.49.20983","article-title":"Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014","volume":"19","author":"Baggi","year":"2014","journal-title":"Euro Surveill"},{"key":"2025073013074257000_1.3.e000180.36","unstructured":"Davey RT . PREVAIL II: A Randomized Controlled Trial of ZMapp\u2122 in Acute Ebola Virus Infection. Presented at the CRO 2016, Abstract No. 77LB. Boston, MA, USA. http:\/\/www.croiconference.org\/sessions\/prevail-ii-randomized-controlled-trial-zmapp%E2%84%A2-acute-ebola-virus-infection (accessed 5 Sep 2016)."},{"key":"2025073013074257000_1.3.e000180.37","doi-asserted-by":"crossref","unstructured":"Warren T , Jordan R , Lo M , et al . Nucleotide Prodrug GS-5734 is a broad-spectrum filovirus inhibitor that provides complete therapeutic protection against the development of Ebola virus disease (EVD) in infected non-human primates. Open Forum Infect Dis (Fall 2015) 2 (suppl 1): doi: 10.1093\/ofid\/ofv130.02 .","DOI":"10.1093\/ofid\/ofv130.02"},{"key":"2025073013074257000_1.3.e000180.38","unstructured":"Gilead Sciences, . Gilead Provides Update on Investigational Compound, GS-5734, for the Treatment of Ebola Virus Disease. 21 October 2015. http:\/\/www.businesswire.com\/news\/home\/20151021005958\/en\/ (accessed 5 Sep 2016)."},{"key":"2025073013074257000_1.3.e000180.39","unstructured":"World Health Organization (14 August 2014). Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD). http:\/\/www.who.int\/mediacentre\/news\/statements\/2014\/ebola-ethical-review-summary\/en\/ (accessed 5 Sep 2016)."},{"key":"2025073013074257000_1.3.e000180.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1201533"},{"key":"2025073013074257000_1.3.e000180.41","doi-asserted-by":"publisher","DOI":"10.1186\/2049-9957-3-35"},{"key":"2025073013074257000_1.3.e000180.42","unstructured":"Aagaard-Hansen J , Chaignat CL . Neglected tropical diseases: equity and social determinants. In: Blas E , Kurup AS, eds . Equity, social determinants and public health programmes. Geneva, Switzerland: WHO, 2010:135\u201357."},{"key":"2025073013074257000_1.3.e000180.43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4269\/ajtmh.15-0229","article-title":"Ebola virus disease: rapid diagnosis and timely case reporting are critical to the early response for outbreak control","volume":"93","author":"Stamm","year":"2015","journal-title":"Am Soc Trop Med Hyg"},{"key":"2025073013074257000_1.3.e000180.44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(15)60232-X","article-title":"Favipiravir for children with Ebola","volume":"385","author":"Bouazza","year":"2015","journal-title":"Lancet"},{"key":"2025073013074257000_1.3.e000180.45","unstructured":"World Health Organization. Interim guidance. Clinical care for survivors of ebola virus disease. Geneva, Switzerland: WHO. 25 January 2016."},{"key":"2025073013074257000_1.3.e000180.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1411471"},{"key":"2025073013074257000_1.3.e000180.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1502918"},{"key":"2025073013074257000_1.3.e000180.48","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60644-4"},{"key":"2025073013074257000_1.3.e000180.49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/524022a","article-title":"The next time. The world is ill-prepared for the next epidemic or pandemic. But the horror of the Ebola outbreak in West Africa may drive change","volume":"524","author":"Butler","year":"2015","journal-title":". Nature"},{"key":"2025073013074257000_1.3.e000180.50","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMp1605847","article-title":"Beyond the Ebola Battle\u2014 winning the war against future epidemics","volume":"375","author":"Dzau","year":"2016","journal-title":"N Engl J Med"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2016-000180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T20:07:51Z","timestamp":1753906071000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2016-000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,11,24]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1136\/bmjgh-2016-000180"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2016-000180","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}